Keytruda + Chemo as 1st Tx for Metastatic TNBC W High PD-L1

Options

Keytruda Plus Chemotherapy Offers More Benefits Than Chemo Alone as First Treatment for Metastatic Triple-Negative Breast Cancer With High Levels of PD-L1
May 14, 2020

Keytruda plus chemotherapy offered better progression-free survival than chemotherapy alone as the first treatment for metastatic triple-negative breast cancer or triple-negative breast cancer that has come back in the breast area but can't be removed with surgery, with high levels of the PD-L1 protein. Read more...

Categories